Amplifyer Bio
Lexington, US · Founded 2023 · Delaware corporation · 10 employees on LinkedIn · 1 known investors
Find your way into Amplifyer Bio
Sign up to see every warm intro you have to Amplifyer Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amplifyer Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.
Founders & leadership
AM

Annie MurphyChief Executive OfficerAnnie Murphy leads Amplifyer Bio, which develops liquid biopsy technology for cancer patients. She has background in product strategy, regulatory approval, and commercialization across diagnostic and therapeutic sectors, with early career experience in leveraged finance.
EK
Eric K. HuangNamed on SEC filing
JC
J. Christopher LoveNamed on SEC filing
VA
Viktor A. AdalsteinssonNamed on SEC filing
Board
TD

SL

Investors · 1
Reported raises · per SEC filings
Form D private placements$7.1M disclosed across 1 round · 2024
▶$7.1MraisedOct 2024 · 12 investors · BiotechnologyRule 506(b)
▶$7.1MraisedOct 2024 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric K. HuangExecutive Officer, Director
- J. Christopher LoveDirector
- Thomas de VlaamDirector
- Viktor A. AdalsteinssonDirector
- Stanley LapidusDirector
- Offering amount
- $7.1M
- Amount sold
- $7.1M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Amplifyer Bio went on to found or lead other companies.
Frequently asked questions
- What does Amplifyer Bio do?
- Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.
- Who are Amplifyer Bio's investors?
- Amplifyer Bio's investors include Pillar VC.
- How much funding has Amplifyer Bio raised?
- Amplifyer Bio has disclosed $7.1M raised across 1 round.
- Where is Amplifyer Bio headquartered?
- Amplifyer Bio is headquartered in Lexington, US.


